Among reproductive system cancers, MIR4435-2HG is highly expressed in tumor tissues and tumor cell lines of ovarian cancer (31–33), cervical cancer (34), and breast cancer (6, 35–37). Here, MIR4435-2HG is linked to neoplasm.